Event
Date: March 24, 2020
Location: Regenstrief Institute, 1101 W. 10th St., Indianapolis, IN 46202

2020 LOINC Conference – Indianapolis

LOINC 2020 Indy Meeting

In-person workshops for March 25 have been cancelled for this event. Committee meetings on March 24 and 26 will be online only.

Join LOINCers from around the globe at this special event featuring informative presentations and—for the first time in the U.S.—both the Laboratory LOINC Committee and Clinical LOINC Committee meetings.

This event will be held at LOINC’s home, Regenstrief Institute in Indiana. Our beautiful facility is the ideal location for three days of learning, collaboration, and networking.

DAY 1: MARCH 24 – Laboratory Committee Meeting
The Laboratory LOINC Committee convenes on the first day of the conference to hear updates on LOINC adoption and discuss key issues for development and implementation. All are welcome! You may attend as part of the conference or separately at no cost. Remote attendance is also available.

DAY 2: MARCH 25 – Educational Workshops & Presentations
We’re excited to offer a range of hands-on training sessions, with each one led by top LOINCers and implementers. Review the entire schedule and find the options that best fits your needs. During registration, you will select the sessions you plan to attend.

DAY 3: MARCH 26 – Clinical Committee Meeting
The Clinical LOINC Committee will meet on the final day of the conference. Hear updates and issues related to the clinical domain. All committee meetings are open to the public and free. Remote attendance is available for this event as well.

Registration deadline is March 19!

LEARN MORE & REGISTER

Related News

National study confirms breakthrough COVID cases are less severe than COVID in unvaccinated adults

National study confirms breakthrough COVID cases are less severe than COVID in unvaccinated adults

Hospitalizations, ICU admissions, and hospital deaths lower for those who are vaccinated and boosted Individuals who, despite having been

April Savoy, PhD

Redesigning diabetes technology to detect low blood sugar in older adults with diabetes and Alzheimer’s disease

Regenstrief Institute Research Scientist April Savoy, PhD, a human factors engineer and health services researcher, is developing and testing

illustration of digestive tract with magnifier and stool sample container

New study provides evidence for three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

A scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for individuals

Dr. Tom Imperiale on tailoring colonoscopy screening for 45- to 49-year-olds

Dr. Tom Imperiale on tailoring colonoscopy screening for 45- to 49-year-olds

Dr. Tom Imperiale explains why physicians should be good stewards of colonoscopy resources.  [button_links href=”https://www.regenstrief.org/article/regenstrief-researcher-calls-for-tailoring-colorectal-cancer-screening-45-49-year-olds/” title=”Read the full